MECP2 and Parkinson disease: To confirm whether expression of Nrf2, MeCP2, and BDNF in the striatum are altered in patients of PD, we used postmortem brain samples from patients with DLB, since the postmortem pathological changes of DLB patients are similar to PD patients [36].